Cargando…
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Our objective was to evaluate the effect of the COX-2 inhibitor, celecoxib, on (1) proliferation and apoptosis in human ovarian cancer cell lines and primary cultures of ovarian cancer cells, and (2) inhibition of tumor growth in a genetically engineered mouse model of serous ovarian cancer under ob...
Autores principales: | Suri, Anuj, Sheng, Xiugui, Schuler, Kevin M., Zhong, Yan, Han, Xiaoyun, Jones, Hannah M., Gehrig, Paola A., Zhou, Chunxiao, Bae-Jump, Victoria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129955/ https://www.ncbi.nlm.nih.gov/pubmed/27074576 http://dx.doi.org/10.18632/oncotarget.8659 |
Ejemplares similares
-
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017) -
The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
por: Stine, Jessica E., et al.
Publicado: (2015) -
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
por: Yuan, Lingqin, et al.
Publicado: (2015) -
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer
por: Fan, Yali, et al.
Publicado: (2022) -
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
por: Zhang, Lu, et al.
Publicado: (2016)